Micronomicin
| Clinical data | |
|---|---|
| Other names | (2R,3R,4R,5R)-2-[(1S,2S,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(methylaminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-methylaminooxane-3,5-diol |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Eye drops, IV |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H41N5O7 |
| Molar mass | 463.576 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 260 °C (500 °F) (dec.) |
| |
| |
| (verify) | |
Micronomicin (INN) is an aminoglycoside antibiotic for use on the eye.